CSX Chief Financial Officer to Address Baird Global Industrial Conference
Get Alerts CSX Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 1.1%
Revenue Growth %: +9.5%
Join SI Premium – FREE
JACKSONVILLE, Fla., Nov. 02, 2022 (GLOBE NEWSWIRE) -- CSX Corp. (NASDAQ: CSX) Executive Vice President and Chief Financial Officer, Sean Pelkey, will address the 2022 Baird Global Industrial Conference in Chicago on Wednesday, November 9, at 10:40 Eastern time.
This address will be broadcast live via webcast at http://investors.csx.com. A replay will be available following the conclusion of this event. This announcement, as well as additional financial information, is available on the company’s website at http://investors.csx.com.
About CSX
CSX, based in Jacksonville, Florida, is a premier transportation company. It provides rail, intermodal and rail-to-truck transload services and solutions to customers across a broad array of markets, including energy, industrial, construction, agricultural and consumer products. For nearly 200 years, CSX has played a critical role in the nation’s economic expansion and industrial development. Its network connects every major metropolitan area in the eastern United States, where nearly two-thirds of the nation’s population resides. It also links more than 240 short-line railroads and more than 70 ocean, river and lake ports with major population centers and farming towns alike. More information about CSX Corporation and its subsidiaries is available at www.csx.com. Like us on Facebook (http://facebook.com/OfficialCSX) and follow us on Twitter (http://twitter.com/CSX).
Contact:
Matthew Korn, CFA, Investor Relations
904-366-4515
Bryan Tucker, Corporate Communications
855-955-6397
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Interim Financial Report 2026 now available
- Goliath Intersects 26.80 g/t Au Over 2.30 Meters Within 14.28 g/t Au Over 4.32 Meters From The New Volcanic Wedge Zone Between The Bonanza And Golden Gate Zones That Remains Open For Expansion, On The
- Ethris and EIB sign €30M financing under HERA Invest to advance further clinical development of broad-spectrum nasal antiviral
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesRelated Entities
Robert W Baird, TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share